Therakos’ Cellex extracorporeal photopheresis system is used to administer autologous immune cell therapy for the treatment of cutaneous T-cell lymphoma (CTCL), the two most common forms of which include mycosis fungoides (up to 20,000 case per year in the US) and Sézary Syndrome, which is an aggressive form of the disease. in total, CTCL’s account for less than 4% of all non-Hodgkins lymphomas. Continue reading
Regen Biopharma recently filed an IND (Investigational New Drug Application) with the FDA to permit the initiation of Phase 1 clinical trials of its dCellVax treatment for advanced breast cancer. Continue reading
Tumor Infiltrating Lymphocytes (TILs) are cytotoxic T-cells that are found in tumors. They serve to destroy cancer, or at least keep cancer at bay. Adoptive immunotherapy, Continue reading